Hank Schmidt, MD, PhD
Department of Surgery
Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, Dubin Breast Center of the Tisch Cancer Institute, USA
Dr Schmidt is a board certified surgeon specializing in surgical oncology and particularly in care of patients with breast cancer. He is trained in Molecular Medicine and Genetics with post-doctoral experience in cell signaling, cancer biology, and translational research for development of novel targeted therapies. Currently he is director of the Cancer Risk Program at the Dubin Breast Center at Mount Sinai with expertise in management of patients at high risk for breast cancer and other malignancies. Dr Schmidt is a Principal Investigator of the Breast Cancer Biospecimen Repository and as a member of the Tisch Cancer Institute, he is involved in multiple clinical/translational studies aimed at improving outcomes for breast cancer patients.
Implementation of truly personalized medicine in breast cancer through development of new blood and tissue biomarkers, neoadjuvant protocols and patient derived tumor models to understand mechanisms of therapeutic resistance.